Variant report
Variant | nsv520487 |
---|---|
Chromosome Location | chr4:69083953-69095197 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:22)
- CpG islands (count:122)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:22 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr4:69093019-69093284 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr4:69086517-69086666 | K562 | blood: | n/a | n/a |
3 | CTCF | chr4:69093640-69093790 | GM12867 | blood: | n/a | n/a |
4 | CUX1 | chr4:69094758-69095035 | K562 | blood: | n/a | n/a |
5 | CUX1 | chr4:69094812-69094954 | GM12878 | blood: | n/a | n/a |
6 | FOS | chr4:69083797-69084101 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
7 | FOS | chr4:69083875-69084084 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
8 | FOS | chr4:69083789-69084101 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
9 | FOS | chr4:69083799-69084110 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
10 | GTF2F1 | chr4:69084062-69084217 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | JUND | chr4:69092394-69092663 | HepG2 | liver: | n/a | n/a |
12 | JUND | chr4:69086518-69086793 | HepG2 | liver: | n/a | n/a |
13 | MAFF | chr4:69090792-69090824 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr4:69090740-69090805 | HepG2 | liver: | n/a | chr4:69090767-69090778 |
15 | POLR2A | chr4:69088902-69088957 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr4:69094274-69094716 | H1-neurons | neurons: | n/a | n/a |
17 | POLR2A | chr4:69085264-69085321 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr4:69094277-69094747 | H1-neurons | neurons: | n/a | n/a |
19 | REST | chr4:69093993-69095015 | H1-neurons | neurons: | n/a | n/a |
20 | REST | chr4:69094180-69094914 | H1-neurons | neurons: | n/a | n/a |
21 | TCF7L2 | chr4:69088824-69089063 | HepG2 | liver: | n/a | n/a |
22 | ZNF384 | chr4:69088371-69088388 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:69084723-69084773 | GM06990 | blood: | n/a |
2 | chr4:69084723-69084773 | A549 | lung: | n/a |
3 | chr4:69093675-69093725 | Hepatocyte | liver: | n/a |
4 | chr4:69093675-69093725 | LNCaP | prostate: | n/a |
5 | chr4:69093675-69093725 | SK-N-SH_RA | brain: | n/a |
6 | chr4:69084723-69084773 | BE2_C | brain: | n/a |
7 | chr4:69093675-69093725 | HCPEpiC | choroid plexus: | n/a |
8 | chr4:69093675-69093725 | SKMC | muscle: | n/a |
9 | chr4:69093675-69093725 | SK-N-MC | brain: | n/a |
10 | chr4:69093675-69093725 | IMR90 | lung: | fetal |
11 | chr4:69093675-69093725 | Jurkat | blood: | n/a |
12 | chr4:69093675-69093725 | Caco-2 | colon: | n/a |
13 | chr4:69084723-69084773 | HRE | kidney: | n/a |
14 | chr4:69093675-69093725 | AG04450 | lung: | fetal |
15 | chr4:69093675-69093725 | CMK | blood: | n/a |
16 | chr4:69084723-69084773 | Hepatocyte | liver: | n/a |
17 | chr4:69084723-69084773 | ProgFib | skin: | n/a |
18 | chr4:69093675-69093725 | ovcar-3 | ovarian: | n/a |
19 | chr4:69093675-69093725 | PFSK-1 | brain: | n/a |
20 | chr4:69084723-69084773 | IMR90 | lung: | fetal |
21 | chr4:69084723-69084773 | CMK | blood: | n/a |
22 | chr4:69093675-69093725 | HIPEpiC | eye: | n/a |
23 | chr4:69084723-69084773 | HUVEC | blood vessel: | n/a |
24 | chr4:69093675-69093725 | NB4 | blood: | n/a |
25 | chr4:69093675-69093725 | HAEpiC | amniotic membrane: | n/a |
26 | chr4:69093675-69093725 | AG10803 | skin: | n/a |
27 | chr4:69093675-69093725 | AG09309 | skin: | n/a |
28 | chr4:69084723-69084773 | GM12892 | blood: | n/a |
29 | chr4:69084723-69084773 | AG04449 | skin: | fetal |
30 | chr4:69084723-69084773 | GM12891 | blood: | n/a |
31 | chr4:69093675-69093725 | RPTEC | kidney: | n/a |
32 | chr4:69084723-69084773 | PrEC | prostate: | n/a |
33 | chr4:69093675-69093725 | NHDF-neo | bronchial: | n/a |
34 | chr4:69093675-69093725 | HepG2 | liver: | n/a |
35 | chr4:69093675-69093725 | NHBE | bronchial: | n/a |
36 | chr4:69093675-69093725 | GM06990 | blood: | n/a |
37 | chr4:69084723-69084773 | ECC-1 | luminal epithelium: | n/a |
38 | chr4:69084723-69084773 | AG09309 | skin: | n/a |
39 | chr4:69093675-69093725 | HCF | heart: | n/a |
40 | chr4:69084723-69084773 | Hela-S3 | cervix: | n/a |
41 | chr4:69084723-69084773 | Caco-2 | colon: | n/a |
42 | chr4:69084723-69084773 | HEEpiC | esophagus: | n/a |
43 | chr4:69084723-69084773 | U87 | brain: | n/a |
44 | chr4:69093675-69093725 | A549 | lung: | n/a |
45 | chr4:69093675-69093725 | HRE | kidney: | n/a |
46 | chr4:69093675-69093725 | HEEpiC | esophagus: | n/a |
47 | chr4:69084723-69084773 | PFSK-1 | brain: | n/a |
48 | chr4:69093675-69093725 | HL-60 | blood: | n/a |
49 | chr4:69084723-69084773 | MCF-7 | breast: | n/a |
50 | chr4:69093675-69093725 | AoSMC | blood vessel: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:69087616..69090439-chr4:69090621..69093039,2 | K562 | blood: | |
2 | chr4:69084812..69087062-chr4:69097475..69100132,2 | K562 | blood: | |
3 | chr4:69087616..69090439-chr4:69090621..69093039,2 | K562 | blood: | |
4 | chr4:69078600..69080157-chr4:69085569..69088456,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TMPRSS11BNL | TF binding region |
ENSG00000250026 | TF binding region |
TMPRSS11BNL | CpG island |
ENSG00000250026 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12512581 | chr4:69083953-69083954 | Enhancers | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539727826 | chr4:69083963-69083964 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs11447187 | chr4:69084008-69084009 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs397792446 | chr4:69084010-69084011 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs139543060 | chr4:69084085-69084086 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs538424606 | chr4:69084102-69084103 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs75942551 | chr4:69084118-69084119 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs145174664 | chr4:69084178-69084179 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs190890629 | chr4:69084724-69084725 | Inactive region | CpG island | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs549689898 | chr4:69084728-69084729 | Inactive region | CpG island | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs376174880 | chr4:69085265-69085266 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs11735405 | chr4:69085306-69085307 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs182859300 | chr4:69086622-69086623 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs541681920 | chr4:69086625-69086626 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs535754708 | chr4:69086663-69086664 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs555636570 | chr4:69086664-69086665 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs555252280 | chr4:69086681-69086682 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs553101007 | chr4:69094040-69094041 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs573540326 | chr4:69094112-69094113 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs75738474 | chr4:69094116-69094117 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs534939831 | chr4:69094126-69094127 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs370931940 | chr4:69094182-69094183 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs544765793 | chr4:69094248-69094249 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs76640369 | chr4:69094259-69094260 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs7434397 | chr4:69094265-69094266 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs545771633 | chr4:69094286-69094287 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs143345956 | chr4:69094365-69094366 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs573175416 | chr4:69094373-69094374 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs542113732 | chr4:69094391-69094392 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs561902039 | chr4:69094415-69094416 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs189903902 | chr4:69094446-69094447 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs75647314 | chr4:69094459-69094460 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs375856240 | chr4:69094460-69094461 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs181158969 | chr4:69094466-69094467 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs34044450 | chr4:69094472-69094473 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs368872870 | chr4:69094491-69094492 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs138554652 | chr4:69094492-69094493 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs374890990 | chr4:69094504-69094505 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs2319797 | chr4:69094507-69094508 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs369616775 | chr4:69094516-69094517 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs565709264 | chr4:69094534-69094535 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs368172710 | chr4:69094559-69094560 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs201006796 | chr4:69094565-69094566 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs2319796 | chr4:69094575-69094576 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs373081446 | chr4:69094602-69094603 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs563351333 | chr4:69094610-69094611 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs374678136 | chr4:69094612-69094613 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs373313630 | chr4:69094618-69094619 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs112789961 | chr4:69094624-69094625 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs370127147 | chr4:69094625-69094626 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Graft versus host disease | 20877625 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Osteoporosis | 20877625 | CNVD |
Osteoporosis | 19737800 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Oral cancer | 21386901 | CNVD |
Alcoholism | 21790672 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 19287141 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Ollier disease | 21235737 | CNVD |
Autism | 21865298 | CNVD |
Rett syndrome | 21593744 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Oligozoospermia | 20877625 | CNVD |
Sertoli-cell only syndrome | 20877625 | CNVD |
Thoracic aortic aneurysm | 21698135 | CNVD |
Breast cancer | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69080400-69084200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr4:69082000-69084200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:69082200-69084200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr4:69083200-69084000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr4:69083400-69084200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |